FEBRUARY 2025LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSThe Rub: Medical Affairs is Far More than a Commodity in Rare and Genetic DiseaseHenry David Cremisi, MD FACP, Executive Medical Director, Medical Affairs, Caidya18Bridging the Diversity DivideVictoria Sanjurjo, Director of Clinical Development, Ionis Pharmaceuticals, Inc26Patient-Centric Approach to Accelerating Clinical TrialsAnita Nelsen, President, Clinical Trial Operations,Allucent20Applications of spatial omics technologies in oncology drug discovery and developmentHua Gong, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab29Machine Learning Expedition in Physician Segmentation Helps Identify New Clinical Trial SitesMichael Shim, National Director, Medical Affairs at Syneos Health, Larry Dollar, Vice President Medical Affairs, Syneos Health, and Drew Beck Head of Strategy, Growth, and Innovation, Syneos Health, Inc32AMD GENETIC TESTING COMPANY OF THE YEAR 2025Visible GenomicsScott A Rediger, Chief Executive Officer24Genetic Insights into Age-Related Macular Degeneration22Development of Monoclonal Antibodies16STATE OF THE INDUSTRYFUELING BIOTECH INNOVATIONDaniella Kranjac, Founding General PartnerAvant Bio28
< Page 4 | Page 6 >